CURE saw its Momentum Indicator move below the 0 level on December 08, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned negative. In of the 92 cases, the stock moved further down in the following days. The odds of a decline are at .
The 10-day RSI Indicator for CURE moved out of overbought territory on December 01, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for CURE turned negative on December 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CURE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CURE broke above its upper Bollinger Band on November 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 50-day moving average for CURE moved above the 200-day moving average on November 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CURE advanced for three days, in of 347 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 271 cases where CURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Category Trading
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NRMGX | 18.93 | 0.17 | +0.91% |
| Neuberger Berman Mid Cap Growth R6 | |||
| VSMIX | 31.51 | 0.24 | +0.77% |
| Invesco Small Cap Value Y | |||
| MYITX | 10.44 | 0.07 | +0.68% |
| NYLI WMC International Research Eq Cl A | |||
| PXWEX | 37.60 | 0.13 | +0.35% |
| Impax Ellevate Global Women's Ldr Inv | |||
| APLIX | 13.60 | N/A | N/A |
| Cavanal Hill Hedged Equity Income Inv | |||
A.I.dvisor indicates that over the last year, CURE has been loosely correlated with SPXL. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CURE jumps, then SPXL could also see price increases.
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | +2.77% | ||
| SPXL - CURE | 57% Loosely correlated | +0.70% | ||
| SSO - CURE | 56% Loosely correlated | +0.48% | ||
| QULL - CURE | 50% Loosely correlated | +1.29% | ||
| TQQQ - CURE | 43% Loosely correlated | -0.95% | ||
| QLD - CURE | 43% Loosely correlated | -0.65% | ||
More | ||||